Baird Medical Investment Holdings Ltd
Nasdaq · CIK 0001982444 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$22.5M
Cost Of Revenue
$3.7M
Gross Profit
$18.9M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $22.5M | - | - |
| Cost Of Revenue | $3.7M | - | - |
| Gross Profit | $18.9M | - | - |
| Operating Income | $-25.6M | - | - |
| Net Income | $-27.3M | - | - |
| Eps Basic | -0.98 | - | - |
| Eps Diluted | -0.98 | - | - |
| Cash And Equivalents | $178,321 | - | - |
| Total Assets | $69.7M | - | - |
| Total Liabilities | $38.5M | - | - |
| Shareholders Equity | $31.4M | - | - |
| Operating Cash Flow | $-1.3M | - | - |
| Capital Expenditures | $42,315 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 20-F/A | Baird Medical Investment Holdings Ltd | 2026-07-27 | 0001104659-26-087081 |
| 20-F | Baird Medical Investment Holdings Ltd | 2026-04-24 | 0001104659-26-048641 |
| 6-K | Baird Medical Investment Holdings Ltd | 2025-12-05 | 0001104659-25-118866 |